Liang Y - Search Results

1

Overexpression of progesterone receptor membrane component 1: possible mechanism for increased breast cancer risk with norethisterone in hormone therapy.

Neubauer H, Ruan X, Schneck H, Seeger H, Cahill MA, Liang Y, Mafuvadze B, Hyder SM, Fehm T, Mueck AO. Neubauer H, et al. Among authors: liang y. Menopause. 2013 May;20(5):504-10. doi: 10.1097/GME.0b013e3182755c97. Menopause. 2013. PMID: 23615641

2

Estradiol down-regulates CD36 expression in human breast cancer cells.

Uray IP, Liang Y, Hyder SM. Uray IP, et al. Among authors: liang y. Cancer Lett. 2004 Apr 15;207(1):101-7. doi: 10.1016/j.canlet.2003.10.021. Cancer Lett. 2004. PMID: 15050739

3

Proliferation of endothelial and tumor epithelial cells by progestin-induced vascular endothelial growth factor from human breast cancer cells: paracrine and autocrine effects.

Liang Y, Hyder SM. Liang Y, et al. Endocrinology. 2005 Aug;146(8):3632-41. doi: 10.1210/en.2005-0103. Epub 2005 Apr 21. Endocrinology. 2005. PMID: 15845615

4

p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.

Liang Y, Wu J, Stancel GM, Hyder SM. Liang Y, et al. J Steroid Biochem Mol Biol. 2005 Feb;93(2-5):173-82. doi: 10.1016/j.jsbmb.2004.12.011. Epub 2005 Jan 28. J Steroid Biochem Mol Biol. 2005. PMID: 15860260

5

Complex agonist-like properties of ICI 182,780 (Faslodex) in human breast cancer cells that predominantly express progesterone receptor-B: implications for treatment resistance.

Wu J, Liang Y, Nawaz Z, Hyder SM. Wu J, et al. Among authors: liang y. Int J Oncol. 2005 Dec;27(6):1647-59. Int J Oncol. 2005. PMID: 16273221

6

Vascular endothelial growth factor induces proliferation of breast cancer cells and inhibits the anti-proliferative activity of anti-hormones.

Liang Y, Brekken RA, Hyder SM. Liang Y, et al. Endocr Relat Cancer. 2006 Sep;13(3):905-19. doi: 10.1677/erc.1.01221. Endocr Relat Cancer. 2006. PMID: 16954439

7

Re-activation of the p53 pathway inhibits in vivo and in vitro growth of hormone-dependent human breast cancer cells.

Liang Y, Besch-Williford C, Benakanakere I, Hyder SM. Liang Y, et al. Int J Oncol. 2007 Oct;31(4):777-84. Int J Oncol. 2007. PMID: 17786308

8

Progestin-dependent progression of human breast tumor xenografts: a novel model for evaluating antitumor therapeutics.

Liang Y, Besch-Williford C, Brekken RA, Hyder SM. Liang Y, et al. Cancer Res. 2007 Oct 15;67(20):9929-36. doi: 10.1158/0008-5472.CAN-07-1103. Cancer Res. 2007. PMID: 17942925

9

Estrogen regulation of thrombospondin-1 in human breast cancer cells.

Hyder SM, Liang Y, Wu J. Hyder SM, et al. Among authors: liang y. Int J Cancer. 2009 Sep 1;125(5):1045-53. doi: 10.1002/ijc.24373. Int J Cancer. 2009. PMID: 19391135 Free PMC article.

10

Regulation of thrombospondin-1 by natural and synthetic progestins in human breast cancer cells.

Hyder SM, Liang Y, Wu J, Welbern V. Hyder SM, et al. Among authors: liang y. Endocr Relat Cancer. 2009 Sep;16(3):809-17. doi: 10.1677/ERC-08-0311. Epub 2009 Jul 1. Endocr Relat Cancer. 2009. PMID: 19570906

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23,447 results

Search Page

Filters